Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05921_nanopub.RAYFIcgtAmJBp2D3Syz3XXYt0oJoyZkpFIjJxaCFZB-Xo#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05921 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05921 label "CRA-024781 [drugbank:DB05921]" assertion.
- drugbank:DB05921 seeAlso DB05921 assertion.
- drugbank:DB05921 identifier "drugbank:DB05921" assertion.
- drugbank:DB05921 description "CRA-024781 is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. It is being developed by Celera Genomics for the treatment of cancer and currently under Phase I of clinical trail." assertion.
- drugbank:DB05921 title "CRA-024781" assertion.
- drugbank:DB05921 bio2rdf_vocabulary:identifier "DB05921" assertion.
- drugbank:DB05921 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05921 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05921" assertion.
- drugbank:DB05921 bio2rdf_vocabulary:x-identifiers.org DB05921 assertion.
- drugbank:DB05921 drugbank_vocabulary:drugbank-id "DB05921" assertion.
- drugbank:DB05921 drugbank_vocabulary:x-cas cas: assertion.